Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes | |
Chen, Peng; Chen, Fuchao; Zhou, Benhong | |
刊名 | DRUG DESIGN DEVELOPMENT AND THERAPY
![]() |
2018 | |
卷号 | 12 |
关键词 | ipilimumab sargramostim efficacy safety survival meta-analysis |
ISSN号 | 1177-8881 |
DOI | 10.2147/DDDT.S154258 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4213509 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Chen, Peng,Chen, Fuchao,Zhou, Benhong. Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes[J]. DRUG DESIGN DEVELOPMENT AND THERAPY,2018,12. |
APA | Chen, Peng,Chen, Fuchao,&Zhou, Benhong.(2018).Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes.DRUG DESIGN DEVELOPMENT AND THERAPY,12. |
MLA | Chen, Peng,et al."Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes".DRUG DESIGN DEVELOPMENT AND THERAPY 12(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论